Drug Chirality and its Clinical Significance

1996/01/01 by A. J. Hutt, S. C. Tan, Soo Choon Tan · 3 citations
Biochemistry, Genetics and Molecular Biology · Chemistry · Pharmacology, Toxicology and Pharmaceutics · #Analytical Chemistry and Chromatography #Metabolism and Genetic Disorders #Pharmacogenetics and Drug Metabolism

paper · doi:10.2165/00003495-199600525-00003

crossref issued 1996/01/01 · crossref published 1996/01/01 · crossref published-print 1996/01/01 · openalex publication_date 1996/01/01 · crossref created 2009/03/05 · crossref deposited 2013/01/20 · openalex created_date 2025/10/10 · crossref indexed 2026/07/30 · openalex updated_date 2026/07/31

Citations

• Stereoselectivity of bioactive xenobiotics
• Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology
• Racemic mixtures and single stereoisomers: Industrial concerns and issues in drug development
• The so‐called “interconversion” of stereoisomeric drugs: An attempt at clarification
• Stereochemistry: A source of problems in medicinal chemistry
• The FDA perspective on the development of stereoisomers
• Importance of Drug Enantiomers in Clinical Pharmacology
• Studies on the relationship between chemical constitution and physiological action

Cited by

• Combinatorial QSAR of Ambergris Fragrance Compounds
• Enantiopure Tetrahydro-β-carbolines via Pictet−Spengler Reactions with N-Sulfinyl Tryptamines
• Chiral drugs [wikipedia]